The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWater Intel. Regulatory News (WATR)

Share Price Information for Water Intel. (WATR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 372.50
Bid: 365.00
Ask: 380.00
Change: 0.00 (0.00%)
Spread: 15.00 (4.11%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 372.50
WATR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Initiation of Sales of Sewer Diagnostic Product

10 Nov 2020 07:00

RNS Number : 7527E
Water Intelligence PLC
10 November 2020
 

 

Water Intelligence plc 

Initiation of Commercial Sales of New ProprietarySewer Diagnostic Product

Brisbane Franchise Reacquisition Completed 

Water Intelligence plc (AIM: WATR.L) ("Water Intelligence" or "Group"), a leading multinational provider of precision, minimally-invasive leak detection and remediation solutions for both potable and non-potable water is pleased to announce the initiation of sales from OrcaTM, its proprietary sewer diagnostic product. Such initiation of sales has been delivered on schedule, as guided by the 3Q Trading Update previously released. Commercialization reinforces the Group's leadership in using technology to deliver enhanced value for water infrastructure services. Such value is important both for the Covid-marketplace and for our Green Economy future.

Orca has been in development at the Group's UK-based, Water Intelligence International subsidiary (WII). The proprietary product uses acoustic technology to identify sewer blockages in municipal pipes more effectively than any competitive solution. WII has paid engagements starting with 4 large municipal customers in the UK. The Group expects that such engagements will lead to a broader rollout in 2021 in the United States, Canada and Australia within a subset of the Group's 140+ locations.

Of note, especially for ESG investors, Orca is important to address the collateral effects of climate change. In one of its first commercial engagements, WII deployed Orca working with Thames Water and Lanes Group - the leading provider of wastewater solutions in the UK - to identify which sewers can handle the increased likelihood of flooding - a by-product of climate change.

Orca and its derivative product - PulseTM - are also of critical need in a Covid-influenced marketplace. Sewer clogs and wastewater overflow are becoming more frequent everywhere as citizens have problems disposing of sanitary wipes while sheltering in place. Such blockages are causing second-order public health issues.

The Group's Orca product roll-out strategy for the US will be the same as that previously used for WII's municipal services. The Group will leverage the sales footprint (140+ locations) and brand reputation for water infrastructure services of its American Leak Detection subsidiary ("ALD"). The deployment of the proprietary Orca product will reinforce the current sales of WII municipal services in the United States, increasing that business line's growth trajectory.

WII will also be working with ALD franchisees to commercialize WII's Pulse product during 2021. Pulse is a sewer diagnostic product for residential application. Product development was launched at the annual Franchise Convention in Arizona last March as previously announced. Field tests started in the U.S. during 3Q.

Brisbane

The Group also announces the completion of its reacquisition of the American Leak Detection franchisee in Brisbane, Australia. The Group, on 30 September, announced the signing of the reacquisition transaction pending certain closing requirements. As noted in that release, the Group now has corporate operations in the three largest population centers in Australia. These corporate operations, in addition to contributing direct revenue and profits to the Group, will support ALD franchises in Australia, reinforcing the growth of royalty income for the remaining franchise locations.

Commenting on the Group's performance, Executive Chairman, Dr. Patrick DeSouza remarked: "We are pleased with the initiation of commercial sales of Orca. The product is timely and will add to the growth of our Water Intelligence International subsidiary. Such sales, combined with our recent insurance customer wins, will reinforce our growth trajectory for the remainder of 2020 and 2021. As noted in the release, Orca and its derivative product Pulse contribute solutions for a Covid-marketplace and, more broadly, for the Green Economy. We look forward to continuing to increase our share of a big global market."

 

Enquiries:

Water Intelligence plc

 

Patrick DeSouza, Executive Chairman

Tel: +1 203 654 5426

Adrian Hargrave, VP Corporate Development

 

+44 (0) 7775 701 838

WH Ireland Limited - NOMAD & Broker

Tel: +44 (0) 207 220 1666

Adrian Hadden

 

James Sinclair-Ford

 

 

Matthew Chan

Dowgate Capital Ltd - Broker & Advisor Stephen Norcross

Tel: +44 (0)7920 599 793

 

 

 

 

 

     

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCXKLLBBFLLFBD
Date   Source Headline
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Feb 20247:00 amRNSFull Year Trading Update
1st Feb 20247:00 amRNSNational Insurance Wins
21st Dec 20237:00 amRNSExpansion of Credit Facility
5th Dec 20237:00 amRNSTrading Update
7th Nov 20237:00 amRNSDirectorate Change
11th Oct 20234:01 pmRNSTR-1: Notification of major holdings
19th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSNew Products Update and Notice of Results
26th Jul 202310:55 amRNSResult of AGM
24th Jul 20237:00 amRNSReacquisition of West Covina, California Franchise
7th Jul 20237:00 amRNSIssue of Options
28th Jun 20234:44 pmRNSPosting of Annual Report and Notice of AGM
21st Jun 20237:00 amRNSAudited Results for Year Ended 31 December 2022
10th May 20237:00 amRNSQ1 Trading Update
23rd Feb 20237:00 amRNSTR-1: Standard form notification of major holdings
7th Feb 20237:05 amRNSIssue of Options
7th Feb 20237:00 amRNSTrading Update and Acquisition
17th Nov 20227:00 amRNSTrading Update Q3 2022
22nd Sep 20227:00 amRNSInterim Results
15th Sep 20224:36 pmRNSPrice Monitoring Extension
19th Aug 20223:46 pmRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20225:24 pmRNSExercise of Options
26th Jul 20227:00 amRNSMunicipal Wins in Australia
12th Jul 20227:00 amRNSResult of AGM
16th Jun 20227:00 amRNSAcquisition of Plumbing Company
15th Jun 20224:51 pmRNSPosting of Annual Report and Notice of AGM
9th Jun 20227:00 amRNSAudited Results For Year Ended 31 December 2021
12th May 20227:00 amRNSReacquisition of Central Texas Franchise
9th May 20227:00 amRNSQ1 Trading Update: Accelerating Growth Plan
6th Apr 20228:30 amRNSTransaction in Own Shares and Total Voting Rights
5th Apr 20227:00 amRNS$17 Million Expansion of Credit Facilities
18th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20227:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20227:00 amRNS2021 Trading Results and Operational Highlights
26th Jan 20227:00 amRNSSale of Territory to North Carolina Franchisee
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:36 pmRNSPrice Monitoring Extension
19th Jan 20227:00 amRNSReacquisition of Fort Worth Franchise
20th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Dec 20217:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Dec 20217:00 amRNSReacquisition of South Oregon Franchise
24th Nov 20217:00 amRNSTR-1: Notification of Major Holdings
24th Nov 20217:00 amRNSPDMR Dealing and Issue of New Ordinary Shares
16th Nov 202112:22 pmRNSIssue of new shares in respect of Share Options
12th Nov 20215:43 pmRNSResults of Placing and Exercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.